Companies / Tango Therapeutics, Inc. / Activity
Activity — Tango Therapeutics, Inc.
21 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | Crystal Adam Executive | Sell | Common Stock | $694.2K | -54K -29.03% | 132,873 0.08% of shares | medium |
| Feb 3, 2026 | Weber Barbara Executive | Sell | Common Stock | $370.0K | -30K -1.82% | 1,629,587 0.97% of shares | medium |
| Mar 5, 2026 | Crystal Adam Executive | Sell | Common Stock | $303.8K | -20K -15.24% | 112,622 0.07% of shares | medium |
| Mar 25, 2026 | Crystal Adam Executive | Sell | Common Stock | $241.3K | -12K -9.63% | 112,622 0.07% of shares | medium |
| Feb 3, 2026 | Crystal Adam Executive | Sell | Common Stock | $223.7K | -18K -8.87% | 187,419 0.11% of shares | medium |
| Feb 3, 2026 | Beckman Daniella Executive | Sell | Common Stock | $125.1K | -10K -5.24% | 184,410 0.11% of shares | medium |
| Mar 25, 2026 | Crystal Adam Executive | Exercise | Common Stock | $62.4K | +12K +10.66% | 124,622 0.07% of shares | low |
| Feb 3, 2026 | Weber Barbara Executive | Sell | Common Stock | $4.3K | -333 -0.02% | 1,629,254 0.97% of shares | low |
| Feb 3, 2026 | Crystal Adam Executive | Sell | Common Stock | $2.6K | -201 -0.11% | 187,218 0.11% of shares | low |
| Feb 3, 2026 | Beckman Daniella Executive | Sell | Common Stock | $1.5K | -113 -0.06% | 184,297 0.11% of shares | low |
| Feb 2, 2026 | Crystal Adam Executive | Grant | Common Stock | $0 | +47K +30.00% | 205,670 0.12% of shares | low |
| Feb 2, 2026 | Beckman Daniella Executive | Grant | Common Stock | $0 | +44K +29.50% | 194,614 0.12% of shares | low |
| Feb 2, 2026 | Weber Barbara Executive | Grant | Common Stock | $0 | +38K +2.31% | 1,659,773 0.98% of shares | low |
| Jan 8, 2026 | Peters Malte CEO | Grant | Common Stock | $0 | +350K +2000.00% | 367,500 0.22% of shares | low |
| Jan 2, 2026 | Lee Sung Director | Grant | Common Stock | $0 | +10K | 10,000 <0.01% of shares | low |
| Mar 25, 2026 | Crystal Adam Executive | Exercise | Stock Option (Right to Buy) | — | -12K -2.54% | 460,500 0.27% of shares | low |
| Feb 2, 2026 | Crystal Adam Executive | Grant | Stock Option (Right to Buy) | — | +285K | 284,760 0.17% of shares | low |
| Feb 2, 2026 | Beckman Daniella Executive | Grant | Stock Option (Right to Buy) | — | +266K | 265,980 0.16% of shares | low |
| Feb 2, 2026 | Weber Barbara Executive | Grant | Stock Option (Right to Buy) | — | +222K | 222,132 0.13% of shares | low |
| Jan 8, 2026 | Peters Malte CEO | Grant | Stock Option (Right to Buy) | — | +1.6M | 1,650,000 0.98% of shares | low |
| Jan 2, 2026 | Lee Sung Director | Grant | Stock Option (Right to Buy) | — | +60K | 60,000 0.04% of shares | low |